Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 10

Results: 13

A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer.

Published in:

2017

By:

Wang, Weili;
Liao, Ping;
He, Yijing

Publication type:

Letter

Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case-control study in Northern China.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1265, doi. 10.1007/s00262-017-2018-7

By:

Han, Sheng;
Deng, Jian;
Wang, Zixun;
Liu, Huan;
Cheng, Wen;
Wu, Anhua

Publication type:

Article

Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1287, doi. 10.1007/s00262-017-2020-0

By:

Storr, Sarah;
Safuan, Sabreena;
Ahmad, Narmeen;
El-Refaee, Mohammed;
Jackson, Andrew;
Martin, Stewart

Publication type:

Article

CD45RAFoxp3 regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1275, doi. 10.1007/s00262-017-2021-z

By:

Ihara, Fumie;
Sakurai, Daiju;
Horinaka, Atsushi;
Makita, Yuji;
Fujikawa, Akira;
Sakurai, Toshioki;
Yamasaki, Kazuki;
Kunii, Naoki;
Motohashi, Shinichiro;
Nakayama, Toshinori;
Okamoto, Yoshitaka

Publication type:

Article

In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1307, doi. 10.1007/s00262-017-2022-y

By:

Díaz-Rodríguez, Yildian;
Cordeiro, Paulo;
Belounis, Assila;
Herblot, Sabine;
Duval, Michel

Publication type:

Article

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1249, doi. 10.1007/s00262-017-2025-8

By:

Hamid, Omid;
Hoffner, Brianna;
Gasal, Eduard;
Hong, Jenny;
Carvajal, Richard

Publication type:

Article

Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1295, doi. 10.1007/s00262-017-2026-7

By:

Battella, Simone;
Cox, M.;
Scaleia, Raffaella;
Napoli, Arianna;
Landro, Francesca;
Porzia, Alessandra;
Franchitti, Lavinia;
Mainiero, Fabrizio;
Ruco, Luigi;
Monarca, Bruno;
Santoni, Angela;
Palmieri, Gabriella

Publication type:

Article

Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1345, doi. 10.1007/s00262-017-2027-6

By:

Sonpavde, Guru;
McMannis, John;
Bai, Yu;
Seethammagari, Mamatha;
Bull, Joan;
Hawkins, Victoria;
Dancsak, Theresa;
Lapteva, Natasha;
Levitt, Jonathan;
Moseley, Annemarie;
Spencer, David;
Slawin, Kevin

Publication type:

Article

TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1321, doi. 10.1007/s00262-017-2028-5

By:

Huang, Fang;
Wan, Jiangbo;
Hao, Siguo;
Deng, Xiaohui;
Chen, Linjun;
Ma, Liyuan

Publication type:

Article

Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1333, doi. 10.1007/s00262-017-2029-4

By:

Lövgren, Tanja;
Sarhan, Dhifaf;
Truxová, Iva;
Choudhary, Bhavesh;
Maas, Roeltje;
Melief, Jeroen;
Nyström, Maria;
Edbäck, Ulrika;
Vermeij, Renee;
Scurti, Gina;
Nishimura, Michael;
Masucci, Giuseppe;
Karlsson-Parra, Alex;
Lundqvist, Andreas;
Adamson, Lars;
Kiessling, Rolf

Publication type:

Article

A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1359, doi. 10.1007/s00262-017-2030-y

By:

Patel, Sapna;
Kim, Dae;
Bassett, Roland;
Cain, Suzanne;
Washington, Edwina;
Hwu, Wen-Jen;
Kim, Kevin;
Papadopoulos, Nicholas;
Homsi, Jade;
Hwu, Patrick;
Bedikian, Agop

Publication type:

Article

Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1367, doi. 10.1007/s00262-017-2031-x

By:

Xu, Feng;
Sunderland, Alexander;
Zhou, Yue;
Schulick, Richard;
Edil, Barish;
Zhu, Yuwen

Publication type:

Article

Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab.

Published in:

2017

By:

Heppt, Markus;
Goldscheider, Ilana;
Tietze, Julia;
Berking, Carola

Publication type:

Letter